Professional advisors to the Children's Cause for Cancer Advocacy (CCCA) are among the nation's most distinguished researchers in pediatric oncology. They offer keen insights pro bono to CCCA on issues of national importance in the research, care, treatment, and follow-up of children with cancer and long-term survivors.

C H A I R M A N

David G. Poplack, MD
Elise C. Young Professor of Pediatric Oncology
Head, Hematology Oncology Section
Department of Pediatrics, Baylor College of Medicine
Director, Texas Children's Cancer Center
Houston, TX

M E M B E R S

Robert J. Arceci, MD, PhD
Director of Pediatric Oncology, Department of Pediatric Oncology
Johns Hopkins Hospital, Baltimore, MD

Archie Bleyer, MD
Medical Advisor
St. Charles Medical Center, Bend, OR

Mark Bernstein, MD
Chief of Hematology/Oncology Department
Saint Justine Hospital, Montreal, Quebec, Canada

Robert P. Castleberry, MD
Professor of Pediatrics, Pediatric Hematology/Oncology
University of Alabama at Birmingham, Birmingham, AL

Henry Friedman, MD
Co-Director of the Clinical Neuro-Oncology Program at the Brain Tumor Center
Professor of Pediatrics
Duke University Medical Center, Durham, NC

Daniel M. Green, MD
Staff Physician, Department of Pediatrics
Roswell Park Cancer Institute, Buffalo, NY

Michael P. Link, MD
Professor of Pediatrics
Chief, Division of Pediatric Hematology/Oncology
Stanford University School of Medicine, Stanford, CA

Sharon Murphy, MD
Director, Children's Cancer Research Institute
University of Texas Health Science Center, San Antonio, TX

Gregory H. Reaman, MD
Chairman
Children's Oncology Group, Bethesda, MD

Charles A. Sklar, MD
Associate Attending, Department of Pediatrics
Director, Long Term Follow-Up Program
Memorial Sloan-Kettering Cancer Center, New York, NY

Institutional affiliation noted for purposes of identification only.